Clinical trial
Efficacy of Dapagliflozin Versus Metformin in Polycystic Ovary Syndrome
NCT07810998 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Dapagliflozin Versus Metformin in Polycystic Ovary Syndrome
- Lead sponsor
- Tanta University
- Phase
- Phase 2/3
- Overall status
- Not yet recruiting
- Start date
- September 10, 2026
- Completion date
- May 10, 2027
- Enrollment
- 60 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
poly cystic ovary syndrome